TRAPPC9 and Hyperinsulinemia: To challenge this idea, we first examined whether the treatment with SCH23390 and quinpirole mitigated hyperglycemia, hyperinsulinemia, and hyperprolactinemia in Trappc9-KO mice, as dopamine transmission modulates glucose homeostasis and inhibits prolactin and insulin secretion (40–43).